Mark R. Hellberg
89Patents
17h-index
63Co-inventors
87Inventor score
Filing activity: Jan 22, 1991 → Jul 10, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5607966A | Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory prodrugs | Chemistry; Metallurgy | 74 | Expired |
| US6025392A | substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives | Chemistry; Metallurgy | 66 | Expired |
| US6646001B2 | Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension | Human Necessities | 62 | Expired |
| US5698733A | Use of 9-deoxy prostaglandin derivatives to treat glaucoma | Chemistry; Metallurgy | 40 | Expired |
| US6232344A | 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension | Chemistry; Metallurgy | 38 | Expired |
| US5475034A | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders | Chemistry; Metallurgy | 31 | Expired |
| US5811438A | Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products | Chemistry; Metallurgy | 31 | Expired |
| US6740674B2 | Use of proteasome inhibitors to treat dry eye disorders | Human Necessities | 28 | Expired |
| US5646149A | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents | Human Necessities | 27 | Expired |
| US6660870B1 | 2-acylaminobenzimidazole derivatives for treating glaucoma | Human Necessities | 27 | Expired |
| US5846988A | Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents | Chemistry; Metallurgy | 22 | Expired |
| US5643943A | Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis | Chemistry; Metallurgy | 21 | Expired |
| US5686450A | Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents | Human Necessities | 21 | Expired |
| US5688828A | Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents | Human Necessities | 20 | Expired |
| US6225327A | Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications | Human Necessities | 19 | Expired |
| US6664286B1 | Serotonergic 5ht2 agonists for treating glaucoma | Human Necessities | 19 | Expired |
| US5424321A | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents | Chemistry; Metallurgy | 19 | Expired |
| US6169111A | Conformationally rigid aryl prostaglandins for use in glaucoma therapy | Chemistry; Metallurgy | 15 | Expired |
| US6342524B1 | Use of non-steroidal anti-inflammatory agents in combination with compounds that have FP prostaglandin agonist activity to treat glaucoma and ocular hypertension | Human Necessities | 14 | Expired |
| US7598288B2 | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma | Human Necessities | 14 | Expired |
| US5130309A | Aryloxy and aryloxyalklazetidines as antiarrhythmic and anticonvulsant agents | Chemistry; Metallurgy | 14 | Expired |
| US6645978B1 | Lipoxin A4 and its analogs for the treatment of dry eye | Human Necessities | 14 | Expired |
| US5925673A | Benzofurans and benzopyrans as cytoprotective agents | Chemistry; Metallurgy | 12 | Expired |
| US5998465A | Esters of non-steroidal anti-flammatory carboxylic acids | Chemistry; Metallurgy | 10 | Expired |
| US6200990A | Neuroprotective agents having antioxidant and NMDA antagonist activity | Chemistry; Metallurgy | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.